title: Augmentin reconsidered.
abstract: The antibiotic co-amoxiclav (Augmentin-SmithKline Beecham) was first launched in the UK in 1981. When we reviewed it in 1982, we recommended it as second-line treatment for urinary infections and concluded that its place in other infections was unclear. Here we reassess the value of co-amoxiclav.
mesh_terms: D000658:Amoxicillin / Q000627:therapeutic use; D019980:Amoxicillin-Potassium Clavulanate Combination; D000818:Animals; D001424:Bacterial Infections / Q000188:drug therapy*; D002969:Clavulanic Acids / Q000627:therapeutic use; D006801:Humans
chemical_list: D002969:Clavulanic Acids; D019980:Amoxicillin-Potassium Clavulanate Combination; D000658:Amoxicillin